Financial toxicity in patients with chronic kidney disease undergoing peritoneal dialysis
Hanhan Kong(Shenzhen Third People’s Hospital), Liping Zhang(Shenzhen Third People’s Hospital), Jinbing Bai(Emory University), Huanhuan Li(First Affiliated Hospital of Guangzhou University of Chinese Medicine), Yanqun Liu(Wuhan University), Wujian Peng(Shenzhen Third People’s Hospital), Claire Gong(Emory University), Yumei Liao(Peking University Shenzhen Hospital)
Cited by 2
Related Papers
Dacarbazine Combined Targeted Therapy versus Dacarbazine Alone in Patients with Malignant Melanoma: A Meta-Analysis
|PLoS ONE|2014|66
Daily self‐care practices influence exit‐site condition in patients having peritoneal dialysis: A multicenter cross‐sectional survey
|Journal of Advanced Nursing|2021|21
The Peritoneal Dialysis Telemedicine-assisted Platform Cohort (PDTAP) Study: Design and methods
|Peritoneal Dialysis International|2020|16
Telemedicine and Clinical Outcomes in Peritoneal Dialysis: A Propensity-Matched Study
|American Journal of Nephrology|2022|15